Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

Completed

Phase N/A Results

Summary of Purpose

To study the efficacy and safety of low-molecular-weight heparin in acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • National Foundation of Shanghai Medical Advance

Trial Design

Multi-center, randomized, controlled clinical trial.

Contacts

Not available